SOTAC PHARMACEUTICALS Financial Statement Analysis
|
||
|
The Revenues of SOTAC PHARMACEUTICALS have increased by 34.00% YoY .
The Earnings Per Share (EPS) of SOTAC PHARMACEUTICALS has increased by 87.60 % YoY. |
||
| REVENUES |
| OPERATING MARGIN |
| PROFIT AFTER TAX |
| EPS |
| ROCE |
SOTAC PHARMACEUTICALS Last 5 Annual Financial Results
[NSE : SOTAC]
| Consolidated | Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 |
|---|---|---|---|---|---|
| Revenues | ₹104 Cr | ₹77 Cr | ₹73 Cr | ₹49 Cr | ₹29 Cr |
| Expenses | ₹96 Cr | ₹70 Cr | ₹67 Cr | ₹47 Cr | ₹27 Cr |
| Operating Profit (Excl OI) | ₹8.32 Cr | ₹7.32 Cr | ₹6.17 Cr | ₹1.46 Cr | ₹1.87 Cr |
| Other Income | ₹0.49 Cr | ₹0.35 Cr | ₹0.22 Cr | ₹0.11 Cr | ₹0.22 Cr |
| Interest | ₹1.74 Cr | ₹2.04 Cr | ₹0.57 Cr | ₹1.03 Cr | ₹0.33 Cr |
| Depreciation | ₹3.10 Cr | ₹2.28 Cr | ₹1.13 Cr | ₹2.59 Cr | ₹1.40 Cr |
| Profit Before Tax | ₹3.96 Cr | ₹3.93 Cr | ₹4.70 Cr | ₹-2.06 Cr | ₹0.36 Cr |
| Profit After Tax | ₹3.58 Cr | ₹2.29 Cr | ₹2.88 Cr | ₹-2.37 Cr | ₹0.09 Cr |
| Consolidated Net Profit | ₹4.28 Cr | ₹2.88 Cr | ₹2.88 Cr | ₹-2.37 Cr | ₹0.09 Cr |
| Earnings Per Share (Rs) | ₹7.26 | ₹3.87 | ₹3.58 | ₹12.52 | ₹-10.28 |
| PAT Margin (%) | 9.56 | 3.45 | 2.95 | 3.94 | -4.84 |
| ROE(%) | 18.83 | 12.96 | 27.53 | 63.16 | -85.23 |
| ROCE(%) | 16.40 | 10.22 | 21.50 | 31.31 | -5.71 |
| Total Debt/Equity(x) | 0.82 | 0.55 | 2.21 | 1.12 | 6.87 |
Key Financials |
||
| Market Cap | : | ₹ 117.2 Cr |
| Revenue (TTM) | : | ₹ 95.6 Cr |
| Net Profit(TTM) | : | ₹ 3.8 Cr |
| EPS (TTM) | : | ₹ 3.4 |
| P/E (TTM) | : | 31.0 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| SOTAC PHARMACEUTICALS | -17.8% | -16.8% | -15.1% |
| SUN PHARMACEUTICAL INDUSTRIES | -3% | -3.6% | -4.9% |
| DIVIS LABORATORIES | -3.1% | 0.1% | 11.4% |
| CIPLA | -1.3% | -4.6% | -1.5% |
| TORRENT PHARMACEUTICALS | -3.7% | 4% | 18.8% |
| DR REDDYS LABORATORIES | -4.2% | -7% | -11.4% |
| MANKIND PHARMA | -4.3% | 1.5% | -21.3% |
| ZYDUS LIFESCIENCES | -3.9% | -3% | -8.8% |
| LUPIN | -1.7% | 3% | -2.8% |
SOTAC PHARMACEUTICALS Revenues
[NSE : SOTAC]
| Y-o-Y | 34.00 % |
| 5 Yr CAGR | 38.03 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2025 | ₹104 Cr | 34.00 | |
| Mar2024 | ₹77 Cr | 5.92 | |
| Mar2023 | ₹73 Cr | 49.77 | |
| Mar2022 | ₹49 Cr | 70.76 | |
| Mar2021 | ₹29 Cr | - | |
SOTAC PHARMACEUTICALS Operating Profit
[NSE : SOTAC]
| Y-o-Y | 13.67 % |
| 5 Yr CAGR | 45.28 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹8.32 Cr | 13.67 | |
| Mar2024 | ₹7.32 Cr | 18.52 | |
| Mar2023 | ₹6.17 Cr | 323.97 | |
| Mar2022 | ₹1.46 Cr | -22.01 | |
| Mar2021 | ₹1.87 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | -15.15 % |
| 5 Yr CAGR | 5.24 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2025 | 8.01% | -15.15 | |
| Mar2024 | 9.44% | 11.85 | |
| Mar2023 | 8.44% | 183.22 | |
| Mar2022 | 2.98% | -54.36 | |
| Mar2021 | 6.53% | - | |
SOTAC PHARMACEUTICALS Profit After Tax
[NSE : SOTAC]
| Y-o-Y | 48.65 % |
| 5 Yr CAGR | 164.10 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2025 | ₹4.28 Cr | 48.65 | |
| Mar2024 | ₹2.88 Cr | 0.03 | |
| Mar2023 | ₹2.88 Cr | Positive | |
| Mar2022 | ₹-2.37 Cr | Negative | |
| Mar2021 | ₹0.09 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | 177.10 % |
| 5 Yr CAGR | Positive |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2025 | 9.56 % | 177.10 | |
| Mar2024 | 3.45 % | 16.95 | |
| Mar2023 | 2.95 % | -25.13 | |
| Mar2022 | 3.94 % | Positive | |
| Mar2021 | -4.84 % | - | |
SOTAC PHARMACEUTICALS Earnings Per Share (EPS)
[NSE : SOTAC]
| Y-o-Y | 87.60 % |
| 5 Yr CAGR | Positive |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2025 | ₹7.26 | 87.60 | |
| Mar2024 | ₹3.87 | 8.10 | |
| Mar2023 | ₹3.58 | -71.41 | |
| Mar2022 | ₹13 | Positive | |
| Mar2021 | ₹-10 | - | |
SOTAC PHARMACEUTICALS Return on Capital Employed (ROCE)
[NSE : SOTAC]
| Y-o-Y | 60.47 % |
| 5 Yr CAGR | Positive |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2025 | 16.4% | 60.47 | |
| Mar2024 | 10.22% | -52.47 | |
| Mar2023 | 21.5% | -31.33 | |
| Mar2022 | 31.31% | Positive | |
| Mar2021 | -5.71% | - | |
SOTAC PHARMACEUTICALS Share Price vs Sensex
| Current Share Price | : | ₹106.5 |
| Current MarketCap | : | ₹ 117.2 Cr |
| Updated EOD on | : | Jan 13,2026 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SOTAC PHARMACEUTICALS | -17.8% |
-16.8% |
-15.1% |
| SENSEX | -1.7% |
-1.4% |
7% |
SOTAC PHARMACEUTICALS related INDICES
No BSE index found!
No NSE index found
You may also like the below Video Courses
FAQ about SOTAC PHARMACEUTICALS Financials
How the annual revenues of SOTAC PHARMACEUTICALS have changed ?
The Revenues of SOTAC PHARMACEUTICALS have increased by 34.00% YoY .
How the Earnings per Share (EPS) of SOTAC PHARMACEUTICALS have changed?
The Earnings Per Share (EPS) of SOTAC PHARMACEUTICALS has increased by 87.60 % YoY .
Check out Intrinsic Value of Peers of SOTAC PHARMACEUTICALS
Compare Stock Analytics of Peers of SOTAC PHARMACEUTICALS
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs
